And overall, we found that 15CpGs of PLPP4 in glioma, 3CpGs of PLPP4 in PAAD were significantly associated with prognosis in GLIOMA and PAAD patients, but no significant association in LUAD patients (Table 1). Here, PLPP4 is linked to central nervous system cancer.